{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:51:05Z","timestamp":1793652665117,"version":"4.5.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o Faculdade de Medicina"},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["#2012\/07101-4 and #2012\/09633-3"],"award-info":[{"award-number":["#2012\/07101-4 and #2012\/09633-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Federico Foundation"},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s42358-018-0018-8","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T11:43:53Z","timestamp":1533037433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relevance of serum angiogenic cytokines in adult patients with dermatomyositis"],"prefix":"10.1186","volume":"58","author":[{"given":"Thiago Costa Pamplona","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilda Guimar\u00e3es","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ncl.2014.04.007","volume":"32","author":"MM Dimachkie","year":"2014","unstructured":"Dimachkie MM, Barohn RJ, Amato A. Idiopathic inflammatory myopathies. Neurol Clin. 2014;32:595\u2013628.","journal-title":"Neurol Clin"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;373:393\u20134.","journal-title":"N Engl J Med"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/j.lpm.2011.01.005","volume":"40","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Pathophysiology of inflammatory and autoimmune myopathies. Presse Med. 2011;40:e237\u201347.","journal-title":"Presse Med"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","volume":"37","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Review: an update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol. 2011;37:226\u201342.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"18_CR7","first-page":"966","volume":"34","author":"M Orlandi","year":"2016","unstructured":"Orlandi M, Barsotti S, Cioffi E, Tenti S, Toscano C, Baldini C, et al. One year in review 2016: idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2016;34:966\u201374.","journal-title":"Clin Exp Rheumatol"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5582\/bst.2012.v6.5.229","volume":"6","author":"A Kuwahara","year":"2012","unstructured":"Kuwahara A. Angiogenin expression in the sera and skin of patients with rheumatic diseases. Biosci Trends. 2012;6:229\u201333.","journal-title":"Biosci Trends"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1046\/j.1365-2133.1998.02563.x","volume":"139","author":"K Kikuchi","year":"1998","unstructured":"Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol. 1998;139:1049\u201351.","journal-title":"Br J Dermatol"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.23884","volume":"58","author":"C Grundtman","year":"2008","unstructured":"Grundtman C, Tham E, Ulfgren AK, Lundberg IE. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum. 2008;58:3224\u201338.","journal-title":"Arthritis Rheum"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"219313","DOI":"10.1155\/2013\/219313","volume":"2013","author":"N Volpi","year":"2013","unstructured":"Volpi N, Pecorelli A, Lorenzoni P, Di Lazzaro F, Belmonte G, Agliano M, et al. Antiangiogenic VEGF isoform in inflammatory myopathies. Mediat Inflamm. 2013;2013:219313.","journal-title":"Mediat Inflamm"},{"key":"18_CR12","first-page":"604","volume":"29","author":"A Ishikawa","year":"2011","unstructured":"Ishikawa A, Okada J, Nishi K, Hirohata S. Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis. Clin Exp Rheumatol. 2011;29:604\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0190-9622(96)90603-9","volume":"35","author":"T Kadono","year":"1996","unstructured":"Kadono T, Kikuchi K, Kubo M, Fujimoto M, Tamaki K. Serum concentrations of basic fibroblast growth factor in collagen diseases. J Am Acad Dermatol. 1996;35:392\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10875-007-9083-1","volume":"27","author":"JF Carvalho","year":"2007","unstructured":"Carvalho JF, Blank M, Shoenfeld Y. Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol. 2007;27:246\u201356.","journal-title":"J Clin Immunol"},{"key":"18_CR15","first-page":"603","volume":"30","author":"LG Rider","year":"2003","unstructured":"Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol. 2003;30:603\u201317.","journal-title":"J Rheumatol"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","volume":"40","author":"FW Miller","year":"2001","unstructured":"Miller FW, Rider GL, Chung YL, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2001;40:1262\u201373.","journal-title":"Rheumatology (Oxford)"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International myositis and clinical studies group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford). 2004;43:49\u201354.","journal-title":"Rheumatology (Oxford)"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res. 2010;62:465\u201372.","journal-title":"Arthritis Care Res"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, FrieS JF. The Stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003;1:20.","journal-title":"Health Qual Life Outcomes"},{"key":"18_CR20","first-page":"1545","volume":"33","author":"KE Sada","year":"2006","unstructured":"Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y, et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol. 2006;33:1545\u201352.","journal-title":"J Rheumatol"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/0016-5085(94)90017-5","volume":"106","author":"AU Dignass","year":"1994","unstructured":"Dignass AU, Tsunekawa S, Podolsky DK. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterol. 1994;106:1254\u201362.","journal-title":"Gastroenterol"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1073\/pnas.95.3.1218","volume":"95","author":"EC Holland","year":"1998","unstructured":"Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia- specific gene transfer in mice. Proc Nat Acad Sci USA. 1998;95:1218\u201323.","journal-title":"Proc Nat Acad Sci USA"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/1097-4547(20001001)62:1<40::AID-JNR5>3.0.CO;2-L","volume":"62","author":"WA Hossain","year":"2000","unstructured":"Hossain WA, Morets DK. Fibroblast growth factors (FGF-1. FGF-2) promote migration and neurite growth of mouse cochlear ganglion cells in vitro: immunohistochemistry and antibody perturbation. J Neurosci Res. 2000;62:40\u201355.","journal-title":"J Neurosci Res"},{"key":"18_CR24","first-page":"2010","volume":"218142","author":"YR Yun","year":"2010","unstructured":"Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, et al. Fibroblast growth factors: biology, function and application for tissue regeneration. J Tissue Eng. 2010;218142:2010.","journal-title":"J Tissue Eng"},{"key":"18_CR25","first-page":"55","volume":"1","author":"KN Broadley","year":"1989","unstructured":"Broadley KN, Aquino AM, Hicks B, Ditesheim JA, McGee GS, Demetriou AA, et al. The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor. Biotechnol Ther. 1989;1:55\u201368.","journal-title":"Biotechnol Ther"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/002215549904700104","volume":"47","author":"Z Yablonka-Reuveni","year":"1999","unstructured":"Yablonka-Reuveni Z, Seger R, Rivera AJ. Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histoch Cytoch. 1999;47:23\u201342.","journal-title":"J Histoch Cytoch"},{"key":"18_CR27","first-page":"1181","volume":"7","author":"JE Tengood","year":"2011","unstructured":"Tengood JE, Ridenour R. BrodskYR, Russell AJ, little SR. sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng. Part. 2011;7:1181\u20139.","journal-title":"Part"},{"key":"18_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/01.RES.81.2.282","volume":"81","author":"GJ Delbridge","year":"1997","unstructured":"Delbridge GJ, Khachigian LM. FGF-1 induced platelet-derived growth factor-a chain gene expression in endothelial cells involves transcriptional activation by early growth response factor-1. Circ Res. 1997;81:282\u20138.","journal-title":"Circ Res"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1242\/jcs.113.16.2855","volume":"113","author":"A Facchiano","year":"2000","unstructured":"Facchiano A, De Marchis F, Turchetti E, Facchiano F, Guglielmi M, Denaro A, et al. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor. J Cell Sci. 2000;113:2855\u201363.","journal-title":"J Cell Sci"},{"key":"18_CR30","first-page":"387","volume":"25","author":"S Fukuhara","year":"2010","unstructured":"Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N. Angiopoietin-1\/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol. 2010;25:387\u201396.","journal-title":"Histol Histopathol"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/hh1801.097034","volume":"89","author":"I Kim","year":"2001","unstructured":"Kim I, Moon SO, Park SK, Chae SW, Koh GY. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1. VCAM-1 and E-selectin expression. Circ Res. 2001;89:477\u20139.","journal-title":"Circ Res"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-018-0018-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T14:05:00Z","timestamp":1661695500000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-018-0018-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1186\/s42358-018-0018-8","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"26 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee (HCFMUSP - CAPPesq number 1.545.393) and all patients signed the informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}